Thursday, June 2, 2022

Athos Therapeutics Adds To Board

Los Angeles-based Athos Therapeutics, a startup bitoech company which says it is using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, has named several advisors and a member of its board of directors. According to the company, it has added Yiannis Monovoukas, PhD, MBA, and Monte Stettin as advisors and observers to the Board of Directors of Athos Therapeutics. Stettin is the Founder and CEO of Mahler Development Company; Monovoukas, is founder, President, and CEO of Helios Cardio Inc., the cofounder and Managing Partner at SpringTide Investments, and the cofounder and Managing Partner at Falcon III Ventures.